Drug news
Intuniv is filed in EU for ADHD - Shire
The European Medicines Agency has accepted a filing from Shire for once daily extended release guanfacine for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) for 6 to 17 year olds. The drug is approved in the US as Intuniv and in Canada as Intuniv XR.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.